PA
VIVO

Profund Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Profund Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,881
Closed -$193K – 1532
2016
Q4 		$193K Buy
+10,881
New +$191K 0.01% 1471
2014
Q2 		– Sell
-9,685
Closed -$211K – 1618
2014
Q1 		$211K Sell
9,685
-9,028
-48% -$207K 0.01% 1418
2013
Q4 		$496K Buy
18,713
+1,615
+9% +$39.7K 0.02% 1033
2013
Q3 		$404K Buy
+17,098
New +$399K 0.02% 1088

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Profund Advisors's VIVO Position: Q1 2017 in Review

Profund Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2017, closing a stake of 10,881 shares — an estimated $193K sold.

Profund Advisors first reported a position in VIVO in Q3 2013 and held it in 4 quarters. The position peaked at $496K in Q4 2013. 165 funds tracked by Wall St. Rank hold VIVO as of Q1 2017.

  • Profund Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2017 after selling out during the quarter.
  • Profund Advisors sold 10,881 Meridian Bioscience Inc shares in Q1 2017, an estimated $193K.
  • Profund Advisors first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 4 quarters.
  • Profund Advisors's Meridian Bioscience Inc position peaked at $496K in Q4 2013.
  • 165 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2017.

Based on Profund Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.